Skip to main content

Immune pre-conditioning with a Treg-Selective IL-2 Mutein Suppresses Adaptive Immunity to AAV capsids and facilitates vector redosing in mouse models

Conferences
Ochoa, M; Fergione, S; Yudistyra, V; Fisher, D; Sanchez, E; Asokan, A
Published in: MOLECULAR THERAPY
May 8, 2026

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

MOLECULAR THERAPY

EISSN

1525-0024

ISSN

1525-0016

Publication Date

May 8, 2026

Volume

34

Issue

5

Start / End Page

516 / 517

Related Subject Headings

  • Biotechnology
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ochoa, M., Fergione, S., Yudistyra, V., Fisher, D., Sanchez, E., & Asokan, A. (2026). Immune pre-conditioning with a Treg-Selective IL-2 Mutein Suppresses Adaptive Immunity to AAV capsids and facilitates vector redosing in mouse models. In MOLECULAR THERAPY (Vol. 34, pp. 516–517).
Ochoa, Mark, Sophia Fergione, Vivian Yudistyra, Delaney Fisher, Eliya Sanchez, and Aravind Asokan. “Immune pre-conditioning with a Treg-Selective IL-2 Mutein Suppresses Adaptive Immunity to AAV capsids and facilitates vector redosing in mouse models.” In MOLECULAR THERAPY, 34:516–17, 2026.
Ochoa M, Fergione S, Yudistyra V, Fisher D, Sanchez E, Asokan A. Immune pre-conditioning with a Treg-Selective IL-2 Mutein Suppresses Adaptive Immunity to AAV capsids and facilitates vector redosing in mouse models. In: MOLECULAR THERAPY. 2026. p. 516–7.
Ochoa M, Fergione S, Yudistyra V, Fisher D, Sanchez E, Asokan A. Immune pre-conditioning with a Treg-Selective IL-2 Mutein Suppresses Adaptive Immunity to AAV capsids and facilitates vector redosing in mouse models. MOLECULAR THERAPY. 2026. p. 516–517.

Published In

MOLECULAR THERAPY

EISSN

1525-0024

ISSN

1525-0016

Publication Date

May 8, 2026

Volume

34

Issue

5

Start / End Page

516 / 517

Related Subject Headings

  • Biotechnology
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics